Avantor (AVTR) – Analysts’ Recent Ratings Updates

A number of research firms have changed their ratings and price targets for Avantor (NYSE: AVTR):

• 7/30/2026 – Avantor had its price target raised by Royal Bank Of Canada from $9.00 to $14.00. They now have a “sector perform” rating on the stock.
• 7/30/2026 – Avantor had its “hold” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a $13.00 price target on the stock.
• 7/30/2026 – Avantor was upgraded by Wolfe Research from “strong sell” to “hold”.
• 7/30/2026 – Avantor had its price target raised by Morgan Stanley from $10.00 to $14.00. They now have an “equal weight” rating on the stock.
• 7/30/2026 – Avantor had its price target raised by Stifel Nicolaus from $8.00 to $15.00. They now have a “hold” rating on the stock.
• 7/30/2026 – Avantor had its price target raised by Wells Fargo & Company from $14.00 to $16.00. They now have an “overweight” rating on the stock.
• 7/29/2026 – Avantor was upgraded by Jefferies Financial Group Inc. from “underperform” to “hold”. They now have a $13.00 price target on the stock.
• 7/15/2026 – Avantor had its “hold” rating reaffirmed by TD Cowen.
• 7/8/2026 – Avantor had its price target raised by Citigroup Inc. from $9.00 to $11.00. They now have a “neutral” rating on the stock.
• 7/6/2026 – Avantor was given a new $10.50 price target by Evercore Inc.
• 6/27/2026 – Avantor was upgraded by Wall Street Zen from “hold” to “buy”.
• 6/26/2026 – Avantor is now covered by Sanford C. Bernstein. They set a “market perform” rating and a $10.50 price target on the stock.
• 6/25/2026 – Avantor was upgraded by Sanford C. Bernstein to “hold”.
• 6/24/2026 – Avantor was given a new $8.00 price target by UBS Group AG.
• 6/24/2026 – Avantor had its price target raised by Barclays PLC from $7.00 to $8.00. They now have an “underweight” rating on the stock.

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.